EC
IMPV

Everest Capital’s Imperva, Inc. IMPV Stock Holding History

Everest Capital’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,000
Closed -$1.23M – 47
2014
Q1 		$1.23M Buy
+22,000
New +$1.27M 0.29% 35

Other funds holding IMPV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Everest Capital's IMPV Position: Q2 2014 in Review

Everest Capital sold out of Imperva, Inc. (IMPV) in Q2 2014, closing a stake of 22,000 shares — an estimated $1.23M sold.

Everest Capital first reported a position in IMPV in Q1 2014 and held it in 1 quarter. The position peaked at $1.23M in Q1 2014. 120 funds tracked by Wall St. Rank hold IMPV as of Q2 2014.

  • Everest Capital reported no remaining Imperva, Inc. position as of Q2 2014 after selling out during the quarter.
  • Everest Capital sold 22,000 Imperva, Inc. shares in Q2 2014, an estimated $1.23M.
  • Everest Capital first reported a position in Imperva, Inc. in Q1 2014 and held it in 1 quarter.
  • Everest Capital's Imperva, Inc. position peaked at $1.23M in Q1 2014.
  • 120 funds tracked by Wall St. Rank held Imperva, Inc. as of Q2 2014.

Based on Everest Capital's 13F filing for Q2 2014, filed 14 Aug 2014.